Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia
· Delayed Price · Currency is SAR 181.00
+1.20 (0.67%)
May 13, 2025, 3:13 PM AST
TADAWUL:4015 Revenue
Jamjoom Pharmaceuticals Factory Company had revenue of 457.53M SAR in the quarter ending March 31, 2025, with 18.70% growth. This brings the company's revenue in the last twelve months to 1.39B, up 17.30% year-over-year. In the year 2024, Jamjoom Pharmaceuticals Factory Company had annual revenue of 1.32B with 19.77% growth.
Revenue (ttm)
1.39B
Revenue Growth
+17.30%
P/S Ratio
9.05
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.59B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Sulaiman Al Habib Medical Services Group Company | 11.84B |
| Nahdi Medical Company | 9.82B |
| Mouwasat Medical Services Company | 2.92B |
| Dallah Healthcare Company | 3.21B |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 2.79B |
| Almoosa Health Company | 1.25B |
| National Medical Care Company | 1.38B |
| Al-Dawaa Medical Services Company | 6.59B |